These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6445869)

  • 1. Suppression of T-cell responses to histocompatibility antigens by BCG pre-treatment.
    Orbach-Arbouys S; Castes M
    Immunology; 1980 Feb; 39(2):263-8. PubMed ID: 6445869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR; Okada M; Henney CS
    J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-related changes, including synergy and suppression, in the mixed lymphocyte reaction in long-lived mice.
    Gerbase-DeLima M; Meredith P; Walford RL
    Fed Proc; 1975 Feb; 34(2):159-61. PubMed ID: 123206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
    Hamilton BL; Bevan MJ; Parkman R
    J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI).
    King DP; Srober S; Kaplan HS
    J Immunol; 1981 Mar; 126(3):1140-5. PubMed ID: 6450802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of soluble histocompatibility antigen(s) in the control of transplantation reactions: possible dissociation of the roles of H-2 and non-H-2 antigens in the prevention of mortality induced by graft-versus-host reaction.
    Halle-Pannenko O; Abuaf N; Mathé G
    Transplant Proc; 1976 Jun; 8(2):161-72. PubMed ID: 7038
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction.
    Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503
    [No Abstract]   [Full Text] [Related]  

  • 8. Active suppression masks an underlying enhancement of antibody production in vitro by spleen cells from BCG-infected mice.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1980 Jul; 40(3):303-9. PubMed ID: 6448801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
    Teruya K; Kawakami K; Tohyama M; Saito A
    Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions.
    Schwartz A; Orbach-Arbouys S; Gershon RK
    J Immunol; 1976 Sep; 117(3):871-5. PubMed ID: 8571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of H-2 mutants as models for the study of T cell activation.
    McKenzie IF; Pang T; Blanden RV
    Immunol Rev; 1977; 35():179-230. PubMed ID: 70397
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of T-lymphocyte accumulation during experimental pleural infection induced by Mycobacterium bovis BCG.
    Souza MC; Penido C; Costa MF; Henriques MG
    Infect Immun; 2008 Dec; 76(12):5686-93. PubMed ID: 18809659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
    Solnik C; Gleichmann H; Kavanah M; Schwartz RS
    Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
    [No Abstract]   [Full Text] [Related]  

  • 15. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction.
    Halle-Pannenko O; Bruley-Rosset M; Pritchard LL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):549-50. PubMed ID: 2978923
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the effects of T and macrophage-like suppressor cells on memory cell differentiation in vitro.
    Klimpel GR; Henney CS
    J Immunol; 1978 Aug; 121(2):749-54. PubMed ID: 355552
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
    Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
    Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens.
    Polisson RP; Shearer GM
    J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.